The PTPN22 gene helps keep your immune system’s “on” switches from staying too active, so it can fight germs without overreacting to your own tissues. This gene plays an important role in balancing immune signals, especially in certain white blood cells. Some changes in PTPN22 can make immune responses less controlled and are linked to a higher chance of autoimmune conditions such as type 1 diabetes, rheumatoid arthritis, and lupus. A higher genetic risk does not mean you will develop an autoimmune disease, but it can help explain why autoimmunity runs in some families.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or to regulate activity in the body. Some genes provide the directions for producing proteins, which act as the cell’s working components. Other genes are used mostly to manage how strongly a process operates and when and where it happens. As a group, genes help guide growth and normal body function, and they can also affect how you react to food, stress, or medications. For a deeper look at this subject, you can find more in the LearnHub.
Overview
PTPN22Gene function
What if the gene works
The PTPN22 gene helps set the strength of signals inside immune cells, especially T cells. By acting like a brake, it supports balanced immune responses and reduces the chance of the body mistakenly attacking its own tissues.
Risk
What if the gene does not work
Variants in the PTPN22 gene can weaken immune braking, raising the chance of autoimmune diseases like type 1 diabetes and rheumatoid arthritis. Changes range from milder to more disruptive, affecting which features appear and when symptoms start.
Treatment
What does that mean for your treatment
PTPN22 variants do not currently guide drug choice or dosing in routine care; treatment is tailored to your diagnosis and response. Studies are exploring whether some variants affect response to immune-targeting medicines, but this has not entered everyday prescribing.
Conditions associated with PTPN22
Gene function
What if the gene works
Your immune system has to react strongly to real threats while staying calm around everyday exposures like food proteins and pollen. The PTPN22 gene helps set that balance by fine-tuning how immune cells pass along “go” and “slow down” signals. This description of PTPN22 gene function in the immune system focuses on how it supports normal, well-controlled immune activity.
The PTPN22 gene makes a protein that works like a molecular brake in immune cells. It removes small chemical “on” tags (phosphate groups) from signaling proteins so activation signals do not run hotter than needed.
In T cells, PTPN22 helps set the activation threshold so responses start at the right time and intensity. This supports immune tolerance, meaning the immune system can stay appropriately quiet toward the body’s own tissues and harmless exposures.
In B cells, this gene helps shape how strongly cells respond when they encounter a target. That steady control supports well-matched antibody responses and helps keep immune reactions proportionate.
PTPN22 contributes to how immune cells coordinate inflammatory messages called cytokines (chemical signals between cells). This helps inflammation stay targeted and time-limited as the body handles routine immune challenges.
What is a variant?
A genetic variant refers to a minor difference in the DNA code within a gene. These differences are widespread and are part of typical human variation, including traits like appearance, metabolism, and the way the body reacts to environmental factors. Many variants do not lead to any obvious changes and are simply normal genetic differences. In certain situations, though, a variant can affect how a gene works more significantly and may play a role in, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the PTPN22 gene can shift how strongly your immune system “hits the brakes,” which may influence your tendency toward autoimmune conditions such as rheumatoid arthritis or type 1 diabetes. Some PTPN22 gene variants and autoimmune disease risk links come from common DNA changes that subtly alter immune signaling, while rarer mutations can disrupt the protein more substantially. This spectrum from milder variants to more severe mutations can affect how early immune symptoms appear, how persistent they are, and which body systems are involved.
How variants are linked to conditions
Certain inherited changes in the PTPN22 gene are linked to a higher chance of autoimmune disease. Research shows the PTPN22 gene variant and rheumatoid arthritis connection is one of the strongest, and similar associations are seen with type 1 diabetes, systemic lupus erythematosus, and autoimmune thyroid disease. These results reflect risk in groups of people and do not guarantee that any one person will develop a condition.
A variant is not necessarily a diagnosis
Differences in DNA are expected in humans and are widespread across the population. Many of these genetic variants do not directly affect health and instead reflect normal human diversity. For a lot of genes, having a variant that has been linked to a condition points to a potential association rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. In other situations, one clearly defined variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Changes in the PTPN22 gene can raise the chance of certain autoimmune illnesses, but they do not make illness inevitable, and family history and other genes also matter. For rheumatoid arthritis in particular, smoking is a well-established factor that can further increase risk, especially in people with PTPN22 changes. There is not enough evidence to say specific diets or supplements lower risk from PTPN22.
Inheritance of PTPN22 variants
PTPN22 changes are usually inherited from a parent in an autosomal pattern, meaning you can inherit a copy from either your mother or your father. Any parent can pass a PTPN22 variant to any child, regardless of sex, and you may carry it without developing symptoms. This PTPN22 gene variant inheritance means autoimmune tendency can run in families, but it does not follow a guaranteed pattern in who becomes affected.
What does my PTPN22 result mean for my family?
If you have a change in the PTPN22 gene, seek medical advice if you or close relatives develop ongoing joint pain and swelling, unexplained fatigue, long-lasting diarrhea or belly pain, eye redness with pain, or new rashes. Get help sooner if symptoms affect daily life or keep returning. A PTPN22 result can guide which checkups to prioritize and, in some cases, how treatment is chosen.
Genetic information
Genetic testing
How you find out about variants
You can learn whether you carry a PTPN22 variant through a clinical genetic test using a blood or saliva sample. In PTPN22 genetic testing, a lab reads the DNA code at specific spots or sequences the gene to look for changes. Results typically report which variant was found and whether it is known, likely, or uncertain in meaning.
When should I consider getting a genetic test?
Consider genetic testing for the PTPN22 gene when several close relatives have autoimmune diseases like type 1 diabetes or rheumatoid arthritis, or when you have an autoimmune condition and want a fuller picture of inherited risk. PTPN22 results do not diagnose disease, but they can help explain tendencies and guide conversations about screening and prevention.
A genetic result is only one part of your health story
Genetic test results can be very informative, but what they can tell you varies with the health condition and the specific type of variant found. How your body functions over the years is also shaped by factors like your lifestyle, surroundings, age, and personal medical history. With some conditions, particularly those affected by many genes, genetic information offers helpful background rather than a definite prediction and makes the most sense when considered together with other parts of your care. In other situations, the result can be more straightforward and give a clear explanation. For example, when looking at how people respond to certain medications, genetics can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body responds to a medication, including how well it works and what side effects you might notice. The PTPN22 gene is mainly involved in immune system signaling and is not currently used as a standard pharmacogenetic marker to guide medication choice or dosing. More broadly, people can process the same drug differently because genes can affect drug breakdown, movement through the body, or how strongly a medicine acts on its target. This helps explain why one person may get good symptom relief while another needs a different approach or is more sensitive to side effects.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in your genes can affect the way you respond to medications. It examines links between specific genes and particular drugs to explain why the same treatment may have different effects in different people. With many medicines, genetic factors can influence how powerfully a drug works or how your body breaks it down. This information can support more personalized and better informed treatment choices. More details on this subject are available in the LearnHub.
Drugs influenced by the PTPN22 gene
When should I seek medical advice?
Seek medical advice if you have persistent joint swelling, repeated rashes, or unexplained fatigue, especially with a strong family history. If you know you carry a PTPN22 gene change, contact your clinician if new symptoms start or an autoimmune condition is diagnosed. Sharing this information can guide blood tests, monitoring, and choices about medicines that affect the immune system.
History
PTPN22 became widely known in genetics when studies in the early 2000s linked a specific inherited change to a higher risk of several autoimmune conditions, especially type 1 diabetes and rheumatoid arthritis. In recent decades, awareness of this gene’s role has grown as larger international studies confirmed the association in many populations. The best-studied change is often called R620W (also known as C1858T), and it became a reference point for understanding shared genetic risk across different autoimmune diseases. As genetic testing and biobank research expanded, PTPN22 was repeatedly identified in genome-wide studies, helping shift autoimmune research toward comparing conditions side by side. This work also highlighted how one gene can influence risk in more than one illness without determining who will develop disease.